- OncoTree
- FHPTLD
Loading cancer entity…
Loading cancer entity…
Clinical trials
1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04138875 | A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) | withdrawn | Phase 2 | 0 | Yale UniversityOTHER | 1 | Jun 23, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Jun 23, 2022source: clinicaltrials